Inactive Instrument
CannaVEST Corp Stock Other OTC
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 08-13 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 4.03M 3.48M 3.27M 2.97M 5.59M 386M 5.68M 38.38M 15.04M 193M 15.12M 14.79M 643M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.74M 4.96M 4.67M 4.24M 7.98M 550M 8.1M 54.76M 21.46M 275M 21.57M 21.1M 917M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.97% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 2018-05-30 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 2019-03-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 2018-05-30 |
Jamie Corroon
BRD | Director/Board Member | 56 | 2022-07-20 |
William McCorkle
BRD | Director/Board Member | 58 | 2022-10-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.60% | +0.88% | +75.59% | +124.32% | 1,055B | ||
| +3.33% | +4.35% | +53.82% | +57.17% | 632B | ||
| +3.43% | +3.53% | +25.34% | +72.45% | 442B | ||
| +1.35% | -2.17% | +40.98% | +41.50% | 351B | ||
| +1.75% | -0.24% | +25.28% | +40.46% | 290B | ||
| +2.13% | -0.32% | +0.58% | +10.77% | 243B | ||
| +1.41% | +2.65% | +45.34% | +62.43% | 227B | ||
| +1.35% | -3.53% | -14.72% | -52.63% | 200B | ||
| +3.25% | +5.65% | +21.57% | +89.04% | 172B | ||
| Average | +2.40% | +0.10% | +30.42% | +49.50% | 401.39B | |
| Weighted average by Cap. | +2.79% | +0.23% | +43.70% | +68.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.56M 12.76M 11.6M 21.82M 1.5B 22.14M 150M 58.67M 753M 58.96M 57.68M 2.51B | 13.79M 11.91M 11.21M 10.18M 19.15M 1.32B 19.44M 131M 51.51M 661M 51.77M 50.65M 2.2B |
| Net income | -2.39M -2.07M -1.95M -1.77M -3.33M -229M -3.37M -22.82M -8.94M -115M -8.99M -8.79M -382M | -958K -827K -778K -708K -1.33M -91.79M -1.35M -9.13M -3.58M -45.91M -3.6M -3.52M -153M |
| Net Debt | 325K 281K 264K 240K 451K 31.14M 458K 3.1M 1.21M 15.57M 1.22M 1.19M 51.88M | 1.72M 1.48M 1.4M 1.27M 2.39M 165M 2.42M 16.38M 6.42M 82.33M 6.45M 6.31M 274M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions

















